livehealth.store

Orexigen Therapeutics recalls

Orexigen Therapeutics has 2 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 14 Nov 2018. The most frequent reason is packaging defects.

Total recalls2since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 14 Nov 2018

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why orexigen therapeutics is recalled

Packaging Defects150%
Other Reasons150%

Product types

Antidepressants2100%

By year

20182100%

All orexigen therapeutics recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
14 Nov 2018Drug	CLASS III	Contrave (naltrexone HCl and bupropion HCl) recalledContrave	Orexigen Therapeutics	Packaging Defects	CA
22 Aug 2018Drug	CLASS III	Contrave (naltrexone HCl and bupropion HCl) recalledContrave	Orexigen Therapeutics	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.